Any negotiations are currently in the early stages, sources told Reuters. If a deal closes, Waystar could be taken off the stock market and restructure itself as a private business. 

The deal, which sources told reporters could be finalized as early as next week, would mean GE HealthCare would become the sole owner of the private-equity backed radiopharmaceutical developer.

Once the deal closes, BioReference and its FDA-approved 4Kscore Test—currently owned by Opko Health—will become part of Labcorp, allowing it to expand its blood testing capabilities.

The company does not admit to wrongdoing, but was accused by the U.S. Department of Justice in 2024 of unlawful prescriptions for controlled substances, going on to bill Medicare and other government health programs.

The hack, which was revealed earlier this year in a report from Bleeping Computer, is said to have been limited to a legacy server. Oracle denied its cloud environment had been compromised. 

With its $350M in new funding, EliseAI said it plans to build out its technology and sales force. It currently works with specialty provider groups to automate practice operations such as scheduling and insurance verification.

The new entity, Precure, will be owned by both groups. Its work in detecting early disease for timely intervention stems from a research project launched this summer. The Mayo Clinic said Precure will make the results of that initiative actionable.

The change will begin Oct. 1, impacting 11 states. The effort is part of a plan to eliminate prior authorization approvals for 30% of healthcare services by the end of the year, the insurer confirmed.

The Federal Trade Commission was concerned a buyout by OhioHealth would over-consolidate services in rural parts of the state. With the acquisition, Adena brings its hospital count to five, as opposed to OhioHealth’s 16.